4th Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Firm
Client
Income
$15,750
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); drug safety; Prescription and Generic Drug User Fee legislation

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General Medicare and Medicaid issues including, but not limited to, coverage and reimbursement

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) Stop Tampering of Prescription Pills Act of 2012 (H.R. 6160)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
AMY SHANK 2001-2002 Ofc. of Asst. GOP Leader Don Nickles
DAVID THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6160 (112th), H.R. 1316 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.